Biopreservation Market Size & Growth Forecast 2027–2036, By Segments (Application, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Biopreservation Market size was valued at USD 6.1 billion in 2026 and is projected to grow at a 26.89% CAGR from 2027 to 2036, crossing USD 66.01 billion by 2036. The industry revenue for 2027 is estimated at USD 7.48 billion.
Get more details on this report
Request Free Sample ReportBiopreservation Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 47.70% market share in 2026, supported by advanced biobanking infrastructure, widespread clinical research, established cold-chain systems, and strong demand from pharmaceutical and healthcare laboratories.
- Asia Pacific is projected to grow at a 30.14% CAGR, fueled by expanding life sciences research, rising regenerative medicine investments, growing biobanking activity, and broader adoption of advanced preservation workflows.
Segment Momentum
- Equipment led the biopreservation market with a 75.6% share in 2026 because reliable storage and temperature-control systems are essential for preserving biological materials across laboratories, repositories, and clinical environments.
- Regenerative medicine is expanding fastest because preserving the viability and functional integrity of sensitive cells and tissues has become increasingly important as advanced biologic and precision treatment workflows continue to grow.
Market Expansion Drivers
- Expanding hospital and laboratory usage alongside cell and gene therapy demand.
- Rising government and private funding accelerating biologics and vaccine manufacturing.
- AI-driven predictive models and automated cryopreservation improving sample integrity.
Leading Market Participants
- Prominent players in the biopreservation market include Thermo Fisher Scientific Inc. (United States), Azenta, Inc. (United States), BioLife Solutions, Inc. (United States), Panasonic Holdings Corporation (Japan), MVE Biological Solutions (United States), Stirling Ultracold (United States), X-Therma Inc. (United States), LabVantage Solutions, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 6.1 billion
- 2027 Estimated Market Size: USD 7.48 billion.
- Projected Market Size: USD 66.01 billion by 2036
- Growth Forecast: 26.89% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Bio-banking (Application) | Equipment (Product)
- Emerging Opportunity Segment: Regenerative Medicine (Application) | Media (Product)
Market Growth Drivers and Industry Trends
Expanding hospital and laboratory usage alongside cell and gene therapy demand
Expanding hospital and laboratory usage will drive the biopreservation market growth as increasing cell and gene therapy demand creates greater requirements for preserving biological materials throughout handling and storage processes. Broader use across clinical and laboratory environments increases the need for preservation solutions that help maintain the integrity of valuable biological samples.
Rising government and private funding accelerating biologics and vaccine manufacturing
Rising government and private funding for biologics and vaccine manufacturing will support the biopreservation market by expanding activities that require reliable preservation of biological materials. Increased investment in these manufacturing areas strengthens demand for preservation capabilities across workflows involving sensitive biological products and materials.
AI-driven predictive models and automated cryopreservation improving sample integrity
AI-driven predictive models and automated cryopreservation will boost the biopreservation market as these technologies improve the management of preservation processes and help maintain sample integrity. Greater automation can support more controlled handling and storage conditions, while predictive capabilities assist in optimizing preservation processes for sensitive biological samples.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising demand for biopreservation in cell and tissue storage | 10.00% | Short term (≤ 2 yrs) | North America, Europe (spillover: Asia Pacific) | High | Fast |
| Expansion of biobanking and regenerative medicine applications | 9.00% | Medium term (2–5 yrs) | Europe, North America (spillover: Asia Pacific) | Medium | Moderate |
| Technological advancements in cryopreservation solutions | 8.40% | Long term (5+ yrs) | North America, Europe (spillover: Asia Pacific) | Medium | Slow |
| Expanding hospital and laboratory usage alongside cell and gene therapy demand | 2.60% | High | North America, Europe | High | Near Term |
| Rising government and private funding accelerating biologics and vaccine manufacturing | 2.10% | High | North America, Asia Pacific | High | Mid Term |
| AI-driven predictive models and automated cryopreservation improving sample integrity | 1.70% | Moderate | Europe, Asia Pacific | Emerging | Long Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
In the biopreservation market, North America held the largest share of 47.70% in 2026, underpinned by advanced life sciences infrastructure, extensive biomedical research, and strong demand for technologies that maintain the viability and integrity of biological materials. Growing activity in cell and gene therapy, regenerative medicine, biobanking, and pharmaceutical research is increasing the need for reliable preservation methods across laboratories, healthcare institutions, and biopharmaceutical operations. The region's sophisticated cold-chain infrastructure, established research ecosystem, and emphasis on sample quality and traceability further support adoption. Continued development of preservation technologies, including improved cryogenic systems and controlled storage solutions, is strengthening the role of biopreservation within advanced biological research and therapeutic workflows.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is experiencing the fastest growth as investments in biotechnology, biobanking, advanced healthcare, and pharmaceutical research expand across the region. Increasing development of cell-based therapies and regenerative medicine is creating new requirements for preserving cells, tissues, and other biological materials throughout research and clinical processes. Improvements in laboratory infrastructure and cold-chain capabilities are also enabling broader deployment of specialized preservation technologies. Rising healthcare expenditure and greater emphasis on domestic life sciences capabilities are encouraging institutions to strengthen biological sample management, while expanding research networks are creating additional demand for dependable preservation and storage solutions.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Quality-Centric Storage SystemsGermany prioritizes highly regulated biobanking operations and standardized preservation protocols for clinical and pharmaceutical applications. Demand in Germany is supported by research collaborations and the need for reliable sample integrity management across academic and industrial life sciences programs.
France 🇫🇷
Clinical Sample StewardshipFrance is emphasizing secure storage and management of clinical specimens to support biomedical research and personalized medicine initiatives. The biopreservation market in France benefits from growing integration between hospitals, research institutions, and public health biobanking networks.
Italy 🇮🇹
Research Network ExpansionItaly is gradually expanding biopreservation infrastructure to improve access to high-quality biological samples for research and diagnostics. Italian institutions are prioritizing preservation technologies that enhance sample viability and facilitate collaborative research projects across multiple healthcare centers.
Japan 🇯🇵
Regenerative Medicine SupportJapan's focus on regenerative medicine and stem cell research is encouraging wider adoption of advanced biopreservation solutions. Healthcare providers and research organizations in Japan are emphasizing precise cryogenic storage and traceability systems to manage valuable biological samples.
South Korea 🇰🇷
Cell Therapy InfrastructureSouth Korea is strengthening biopreservation capabilities to support its expanding cell therapy and biopharmaceutical sectors. Investments in biobanks and specialized storage facilities are increasing as South Korean companies seek dependable preservation technologies for research and commercial manufacturing activities.
United States 🇺🇸
Advanced Biobanking HubThe U.S. biopreservation market is driven by expanding cell and gene therapy pipelines and increasing demand for long-term storage of biological materials. U.S. healthcare and research institutions are investing in automated cold-chain infrastructure and validated preservation technologies to support clinical and translational research activities.
Segment Leadership and Growth Trends
Biopreservation Market Share (%), by Application, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportApplication Segment Analysis: Bio-banking (Largest Segment) vs Regenerative Medicine (Fastest-Growing Segment)
Bio-banking accounted for the largest share of the biopreservation market at 67.82% in 2026, reflecting the extensive need to preserve biological samples for research, diagnostics, drug development, and long-term sample management. Effective preservation helps maintain the integrity and viability of cells, tissues, and other biological materials during storage and subsequent use. The expansion of biological sample repositories and increasing research activity are strengthening demand for reliable preservation technologies across biobanking workflows.
Regenerative medicine is emerging as the fastest-growing application as cell-based therapies, tissue engineering, and other regenerative approaches increase the need for dependable preservation of sensitive biological materials. Maintaining cell viability and functional characteristics throughout storage, transportation, and clinical preparation is essential for successful therapeutic applications. As regenerative medicine advances toward broader clinical and translational use, demand for preservation methods that support sensitive cellular and tissue materials is expected to increase.
Product Segment Analysis: Equipment (Largest Segment) vs Media (Fastest-Growing Segment)
The equipment segment held the largest share of the biopreservation market at 75.6% in 2026, driven by the essential role of specialized storage and monitoring systems in maintaining controlled conditions for biological materials. Biopreservation equipment supports precise temperature management, sample storage, and operational reliability, making it fundamental to laboratories, biobanks, and research facilities. Increasing requirements for long-term preservation and stringent sample integrity are sustaining investment in dependable preservation infrastructure.
Media is witnessing the fastest growth as preservation workflows increasingly require specialized formulations capable of maintaining the viability and stability of cells, tissues, and other biological materials. Preservation media can be tailored to the characteristics of specific samples and applications, supporting improved handling and recovery following storage. Growing activity in cell-based research, biopharmaceutical development, and regenerative medicine is creating broader demand for advanced media designed to protect sensitive biological materials throughout preservation processes.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Application | Regenerative Medicine, Bio-banking, Drug Discovery | Bio-banking | Regenerative Medicine |
| Product | Equipment, Media, Laboratory Information Management System (LIMS) | Equipment | Media |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Leading companies in the biopreservation market:
1. Thermo Fisher Scientific Inc. (United States)
2. Azenta Inc. (United States)
3. BioLife Solutions Inc. (United States)
4. Panasonic Holdings Corporation (Japan)
5. MVE Biological Solutions (United States)
6. Stirling Ultracold (United States)
7. X-Therma Inc. (United States)
8. LabVantage Solutions Inc. (United States)
In the biopreservation market, advancements are strengthening long-term biological sample stability and storage reliability. Improved cryopreservation techniques are enhancing cell and tissue viability outcomes. The biopreservation market is also seeing expansion in regenerative and clinical research applications. Continuous innovation is improving preservation efficiency across temperature-controlled systems.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Azenta Inc. (United States) | |||||||
| BioLife Solutions Inc. (United States) | |||||||
| Panasonic Holdings Corporation (Japan) | |||||||
| MVE Biological Solutions (United States) | |||||||
| Stirling Ultracold (United States) | |||||||
| X-Therma Inc. (United States) | |||||||
| LabVantage Solutions Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| DHL Group | Mar-25 | DHL Group acquired CRYOPDP, expanding its life-science logistics network with coverage across 15 countries and handling approximately 600,000 annual ultra-cold shipments. The transaction strengthens DHL’s controlled-temperature logistics infrastructure, enhancing cold-chain distribution capacity critical for biopreservation and biologics supply chains. |
| Teknova | Mar-25 | Teknova and Pluristyx introduced PluriFreeze™, an integrated cryopreservation system designed to improve cell-therapy viability and reduce development timelines. The solution strengthens biopreservation workflows by enhancing cell stability during storage and transport, supporting more efficient scaling of advanced cell-therapy manufacturing and distribution processes. |
| Azenta US, Inc. | Jan-25 | Azenta secured a contract with UK Biocentre to deploy BioArc Ultra automation systems, significantly expanding sample storage and processing capacity by approximately 16 million samples for the Our Future Health initiative. The development strengthens large-scale biobanking infrastructure and enhances automated biopreservation capabilities for population-scale biomedical research. |
| FDA | Dec-24 | The FDA approved Symvess, the first acellular tissue-engineered vessel for extremity trauma, marking a regulatory milestone for preserved biological implants. The approval supports the commercialization of advanced preserved tissue-based medical products, reinforcing the role of biopreservation technologies in regenerative medicine and clinical trauma applications. |
| Merck | 2024 | Merck invested over USD 321.7 million in a new bioprocessing production center in Daejeon, South Korea, marking its largest Life Science investment in the Asia-Pacific region. The facility expands bioproduction and related infrastructure capacity while reinforcing regional supply chain resilience for bioprocessing and preservation-enabled life science applications. |
| Thermo Fisher Scientific | 2024 | Thermo Fisher Scientific launched a new line of ultra-low temperature (ULT) freezers, the TSX Universal Series, designed to improve performance, energy efficiency, and workflow integration in laboratory environments. The systems enhance cold storage reliability and operational efficiency, supporting improved preservation conditions for biological samples and research materials. |
| Avantor | 2023 | Avantor entered into a partnership with Tobin Scientific to strengthen end-to-end cold chain logistics services for biopharma customers in the United States. The collaboration enhances temperature-controlled storage and transport capabilities, addressing increasing demand for specialized logistics supporting sample integrity and biopreservation workflows. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Biopreservation Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| End User | Biopharmaceutical & Biotechnology Companies, Hospitals & Healthcare Institutions, Academic & Research Institutions, Biobanks & Biorepositories |
| Preservation Method | Cryopreservation, Hypothermic Preservation, Lyophilization, Other Preservation Methods |
| Biological Material | Cells, Tissues & Organs, Biological Samples, Microorganisms |
Biopreservation Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Cell and Gene Therapy Preservation Opportunities |
|
| Biobanking Infrastructure Expansion Analysis |
|
| Commercialization Strategy for Emerging Applications |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of biopreservation?
What are the growth projections for the biopreservation industry?
How is expanding cell and gene therapy activity influencing demand in the biopreservation market?
What role is AI and automation playing in improving biopreservation practices?
Why is equipment the largest product segment in the biopreservation market?
Why is regenerative medicine the fastest-growing application in the biopreservation market?
Why is North America the leading region in the biopreservation market?
What factors are accelerating biopreservation market growth in Asia Pacific?
Which companies dominate the biopreservation landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization